Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD).
Total 48218 results
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Belgium, Netherlands, Canada, United States
-
AstraZenecaCompletedCOPDKorea, Republic of, Malaysia, Taiwan, Hong Kong, Philippines
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDUnited States, France, Poland, South Africa, Canada, Germany
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Austria, Bulgaria, Canada, Czech Republic, France, Germany, Hungary, Italy, Lithuania, Netherlands, Poland, South Africa, Spain, United Kingdom
-
Almirall, S.A.Forest LaboratoriesCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Greece, Belgium, Bulgaria, Turkey, Hungary, Slovakia, Spain, United Kingdom, Russian Federation, Ireland
-
Aveiro UniversityFundação para a Ciência e a TecnologiaCompletedChronic Obstructive Pulmonary Disease (COPD)Portugal
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Russian Federation, Taiwan, Canada, Germany, Philippines, South Africa, Spain, United Kingdom, Turkey, Hungary, Guatemala, Australia, Bulgaria, France, Poland, Switzerland, Slovakia, Japan
-
SunovionCompleted
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Turkey
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)China, Australia, India
-
Martini Hospital GroningenUnknownChronic Obstructive Pulmonary Disease (COPD)Netherlands
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAsthma | Chronic Obstructive Pulmonary Disease (COPD)United States
-
Medical University of LodzCompletedAsthma, Chronic Obstructive Pulmonary Disease (COPD)Poland
-
Fondazione Don Carlo Gnocchi OnlusCatholic University of the Sacred HeartCompletedChronic Obstructive Pulmonary Disease (COPD)Italy
-
Beth Israel Deaconess Medical CenterNational Institutes of Health (NIH); National Center for Complementary and...CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Russian Federation, Australia, Czech Republic, Poland
-
Fondazione Salvatore MaugeriCompletedChronic Obstructive Pulmonary Disease (COPD)Italy
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease: COPDSwitzerland
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Australia, Germany, United Kingdom, China, Philippines, Italy, Chile, Taiwan, Thailand, France, Puerto Rico, Israel, Peru, Colombia, Poland, Brazil, Russian Federation, Romania, Greece
-
Inmunotek S.L.Active, not recruitingChronic Obstructive Pulmonary Disease (COPD)Spain
-
Teva Branded Pharmaceutical Products R&D, Inc.WithdrawnChronic Obstructive Pulmonary Disease | COPD
-
National Jewish HealthNational Heart, Lung, and Blood Institute (NHLBI)CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Sweden, France, Italy, Spain, Turkey, United Kingdom, Germany, Denmark, Finland, Netherlands, Norway, Austria, Belgium, Portugal, Greece, Ireland, Switzerland
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDPoland, United Kingdom, Germany, Sweden, Denmark
-
Beaumont HospitalAerogenCompletedChronic Obstructive Pulmonary Disease (COPD)Ireland
-
Sunovion Respiratory Development Inc.CompletedChronic Obstructive Pulmonary Disease | COPDUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Provincial Health Services Authority and other collaboratorsCompletedChronic Obstructive Pulmonary Disease (COPD)Canada
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease | COPDGermany
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Spain, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDAustria, France, Hungary, Italy, Poland, Portugal, Russian Federation, South Africa, Spain, Canada, United Kingdom, Australia, Netherlands, Switzerland
-
VA Office of Research and DevelopmentCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Merck Sharp & Dohme LLCCompletedChronic Obstructive Pulmonary Disease (COPD)
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Japan
-
Hacettepe UniversityAtatürk Chest Diseases and Chest Surgery Training and Research HospitalCompletedChronic Obstructive Pulmonary Disease (COPD)Turkey
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Bulgaria, Czech Republic, Poland, Hungary, Romania, Slovakia
-
Universidade Federal de Sao CarlosCompletedChronic Obstructive Pulmonary Disease (COPD)Brazil
-
Centocor, Inc.CompletedChronic Obstructive Pulmonary Disease | COPD
-
DeyCompleted
-
The Hong Kong Polytechnic UniversityCompleted
-
St. Joseph's Healthcare HamiltonBoeringer IngelheimRecruiting
-
Nuvaira, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)France, Belgium, Netherlands, Austria, Germany, United Kingdom
-
University Hospital, BordeauxCompletedChronic Obstructive Pulmonary Disease (COPD)France
-
University of Erlangen-NürnbergBad Reichenhall Clinic, Center for Rehabilitation, Pulmonology and Orthopedics and other collaboratorsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany
-
Queen's UniversityAstraZenecaCompleted
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Belgium, Poland, Romania, Croatia, Estonia, Netherlands, Slovakia, Latvia, Lithuania, United Kingdom, Argentina, Bulgaria, Serbia, Austria, Hungary, Spain, Greece, Canada, Denmark, Czechia
-
Hasselt UniversityJessa HospitalCompletedChronic Obstructive Pulmonary Disease (COPD)Belgium